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Immunoregulatory activities are mediated, in part, by intercellular signals involving 
products  of the  I-region  (Ia  antigen)  of the  major  histocompatibility  complex  in 
several species.  Human Ia-like antigens were first defined by alloantisera  and subse- 
quently by heteroantisera.  In man, Ia determinants  are expressed on the surface of B 
cells,  monocytes,  and  a  subset  of Null  cells  (1-4).  In contrast,  Ia  antigens  are  not 
readily detectable on T  cells or are, at best, expressed on an extremely small percentage 
of resting T  lymphocytes (4-6). Perhaps of greater importance is the recent finding by 
several  laboratories  that  activated  human T  cells express Ia antigens  (5,  6).  Several 
observations point to the fact that these Ia antigens are intrinsic to the T  cells and are 
not passively absorbed:  (a)  the demonstration of Ia  + T-cell leukemias;  (b) the finding 
that  Ia  antigens  expressed  by  alloactivated  T  cells  in  mixed  lymphocyte  culture 
(MLC) 1 are of the responder and not the stimulator DR specificity; and (c) activated 
T  cells biochemically synthesize Ia antigens de novo (4-8). 
The  present  study was  directed  at  further  characterization  of Ia antigens  which 
appear on human T  cells after activation and the stimuli required for their expression. 
To  avoid  the  complexity  of alloantisera  and  heteroantibodies,  we  utilized  several 
monoclonal  antibodies  including  one  reactive  with  the  Ia  antigen  framework  for 
characterization  of Ia-like  antigens,  a  second  monoclonal  antibody  specific  for the 
entire T-cell population, and a third directed at the T-cell inducer (helper)  subset. In 
the results to be reported below, it will be shown that the total T-cell population and 
individual  subsets of T  cells can be activated to express Ia antigens when stimulated 
by alloantigens or mitogens. In contrast, only the inducer T-cell population expresses 
Ia antigen after activation by tetanus toxoid. 
These  studies  support  the  notion that  T  cells which  do not  proliferate  to soluble 
* Supported in part by National Institutes of Health  training grant 09172 and grants AI 12069, CA 
19589, and CA 06516. 
:~ Recipient of a Cancer Research Institute Fellowship. 
§ Recipient of National Institutes of Health Research Fellowship CA 06270. 
1  Abbreviations used in this paper: Con A, concanavalin A; DTT, dithiothreitol; E, sheep erythrocyte rosette; 
FACS, fluorescence-activated  cell sorter; G/M FITC, fluorescein-conjugated  goat-anti-mouse IgG; MLC, 
mixed lymphocyte culture; NP40, nonidet P40; PHA, phytohemagglutinin; PMSF, phenylmethylsulfonyl; 
STI, soybean trypsin inhibitor. 
1472  J. Exp. MED. © The Rockefeller University Press • 0022-1007/79/12/1472/11  $1.00 
Volume 150  December  1979  1472-1482 E.  L.  REINHERZ  ET AL.  1473 
antigen  do  not  express  Ia-like  molecules  after  exposure  to  antigen.  In  addition, 
pretreatment ofT cells with anti-Ia and complement did not eliminate the appearance 
of Ia antigens on T  cells after activation, therefore, suggesting that activation induces 
the expression of Ia antigen on Ia- T  cells and this expression is not the consequence 
of clonal expansion of a  small subset of Ia  + T  cells. 
Materials  and  Methods 
Production of Monoclonal Antibodies 
IMMUNIZATION AND SOMATIC CELL HYBRIDIZATION.  8-wk-old female mice, strains BALB/cJ or 
CAF1 yhe Jackson Laboratories, Bar Harbor, Maine), were immunized intraperitoneaily with 
2 ×  10  sheep erythroeyte (E)  rosette-purified peripheral T  cells in phosphate-buffered saline 
at 14-d intervals. 4 d after the third immunization, the spleens were removed and a single cell 
suspension was prepared. Cell fusion was carried out according to the procedure developed by 
Kohler and Milstein (9). For each fusion, 1 ×  10  s splenocytes were fused with 35% polyethylene 
glycol (PEG), 5% dimethyl sulfoxide, and  RPMI-1640  (Grand Island Biological Co., Grand 
Island, New York) with 2 X  107 P3X63AgSU1  myeloma cells. 
S~L~CTION AND CROWTH OF HYBRmOMAS.  After cell fusion, cells were cultured in hypoxan- 
thine, aminopterin, and  thymidine medium at 37°C  with 5%  CO2  in a  humid atmosphere. 
Several weeks later, 40-100 pl of supernate from cultures containing hybridomas were tested on 
106 peripheral lymphocytes separated into E rosette positive (E  +) and E rosette negative (E-) 
populations which  were  prepared  from  the  peripheral blood of healthy  human  donors  as 
previously described (10).  Detection of mouse hybridoma antibodies to these cells was deter- 
mined by indirect immunofluorescence. Cells incubated with cell supernates were stained with 
a  fluorescein goat anti-mouse IgG (G/M FITC)  (Mcloy Laboratories Inc., Springfield, Va.) 
and  the  fluorescent cells were  subsequently  analyzed on  the  Cytofluorograf FC200/4800A 
(Ortho  Instruments,  Westwood, Mass.)  as described below.  Hybridoma cultures containing 
antibodies reacting selectively with E + and E- lymphocytes were selected, cloned, and recloned 
by limiting dilution methods  in  the presence of feeder cells. Subsequently, the clones were 
transferred  intraperitoneally by injecting  1 X  107  cells of the  given clone  into  CAF~ mice 
primed with pristane (Aldrich Chemical Co.  Inc., Milwaukee, Wis.). The malignant ascites 
from these mice were then used to characterize lymphocytes as described below. The monoclonal 
antibody product of one of these clones which reacted specifically with E- cells was termed 
OKI1. The OKI1 hybridoma antibody was demonstrated to be of the subclass by the specificity 
of its staining with fluorescein-labeled goat anti-mouse IgG2 (Meioy Laboratories Inc.) and its 
failure  to  be  stained  by  fluorescein-labeled antibodies  against  other  subclasses  cf  mouse 
immunoglobulins. 
Fractionation of Lymphocytes.  Human peripheral blood mononuclear cells were isolated from 
healthy volunteer donors by Ficoll-Hypaque density gradient centrifugation (Pharmacia Fine 
Chemicals, Div. of Pharmacia Inc., Piscataway N.J.). Unfractionated mononuclear cells were 
separated into surface Ig  +  (B)  and  Ig- (T plus Null)  populations by Sephadex G-200 anti- 
F(ab')2 affinity chromatography as  previously described  (11).  T  cells were  recovered  by E 
rosetting the Ig- population with 5% sheep erythrocytes (Microbiological Associates, Walkers- 
ville, Md.). The rosetted mixture was layered over Ficoll-Hypaque and the recovered E + pellet 
treated with 0.155  M  NH4CI.  In addition, the  nonrosetting Ig-  (Null cell)  population was 
harvested from  the  Ficoll interface. The  surface Ig  +  (B)  population was obtained from  the 
Sephadcx G-200 column  after elution with normal gamma globulin as previously described 
(11). Normal human macrophages were obtained from the mononuclear population by adher- 
ence techniques as previously reported (12,  13). 
In experiments designed to obtain highly purified T-cell populations, several alternative 
isolation techniques were employed in addition to those described above. In one approach, T 
cells were E rosetted with sheep erythrocytes as above, reacted with OKT3 and G/M FITC, 
and  the  total T  cells sorted with  OKT3  on  the  fluorescence-activated cell sorter  (FACS-I) 
(Becton, Dickinson & Co., Oxnard, Calif.) as described below. The OKT3 monoclonal antibody 
was previously shown to selectively react with the entire human peripheral T-cell subpopulation 
but  not  B  cells, Null  cells, or macrophages  (14).  In  a  second  approach,  T  cells were  first 1474  Ia DETERMINANTS  ON  HUMAN T  CELLS 
obtained by passage through nylon wool and subsequent E rosetting. This population of nylon- 
passed  E rosetted cells was then utilized either directly or after separation on the FACS with 
OKT4 or OKT3 monoclonal antibody. OKT4 was previously shown to be specific  for  the 
human inducer (helper)  subset (12). 
Isolation of the Cell Surface Antigen Deftned by OKI1.  5 ×  108 cells from the B lymphoblastoid 
cell line Laz 388 were washed and resuspended in 100 ml of methionine-free minimal essential 
medium with Earle's Salts (SMEM). Cells were incubated for  16 h  at 37°(] with  1 mCi of 
[35S]methionine (New England Nuclear, Boston, Mass.) and harvested by centrifugation. Pellets 
were  resuspended in 0.01 M  Tris buffer supplemented with  phenylmethylsulfonyl fluoride 
(PMSF), soybean trypsin inhibitor (STI), and dithiothreitol (DTT). After hypotonic lysis, the 
sample was pelleted at 1,500  g. Supernates were resuspended in 2% nonidet P40 (NP40)  in 0.01 
M  Tris at pH  7.8 supplemented with PMSF, STI, and DTT and stirred on ice for 45 min. 
Insoluble material was pelleted at 13,000g for 20 min and the supernates collected and counted. 
The soluble 3Ss methionine-labeled  membrane extracts (50 X 106 cpm) were applied to a 2- 
ml column of Sepharose 4B-bound lentil lectin (Pharmacia Fine Chemicals, Div. of Pharmacia 
Inc.) at 4°C. The column was washed with 500 ml of lectin buffer (0.001 M Tris HCI pH 7.4, 
0.14  M  NaCI, 0.1  mM Mn CI2, 0.1  mM (]aCl2,  and 0.2% NP40).  Bound glycoproteins were 
then eluted with  a  3%  solution of a-methyl-D-mannoside in lectin buffer.  Peak tubes were 
pooled  and  evenly distributed between  Sepharose-protein A-bound OKI1  and  Sepharose- 
protein A-bound control myeloma ascites.  Samples were  incubated overnight at  4°C  in a 
mechanical rotater and thoroughly washed with buffer containing NP40.  100 p.l of sample 
buffer containing 10% glycerol,  5% mercaptoethanol, 3% sodium dodecyl sulfate (SDS),  and 
0.005% bromophenol blue in 0.125 M Tris HC1 was added to each pelleted Sepharose-protein 
A bound sample before a 5-min incubation at 110°C.  Samples were then loaded onto a 7-20% 
gradient polyacrylamide slab gel (7 X 11 in) (15). Electrophoresis was performed at  150 V for 
18 h. Gels were stained, fixed,  dehydrated, impregnated with 2,5 diphenyloxazole, and dried 
using the method of Bonner and Laskey  (16). A sheet of Kodak X-Omat R  film (Eastman 
Kodak Co., Rochester, N. Y.) was placed on the dried gel and exposed for 48 h at -70°C. 
Cytofluorographic Analysis and Cell Separation.  Cytofluorographic analysis of all cell populations 
was performed by indirect immunofluorescence with fluorescein-conjugated goat  anti-mouse 
IgG  (Meloy Laboratories Inc.)  on a  Cytofluorograf FC200/4800A  (Ortho  Instruments). In 
brief, 2 X  106 cells were treated with 0.15 ml of either of three monoclonal antibodies termed 
OKI1, OKT3 or OKT4, at a  1:1,000 dilution, incubated at 4°C for 30 min, and washed twice. 
The cells were then reacted with 0.15 ml of a  1:40 dilution of G/M FITC for 30 min at 4°C, 
centrifuged, and washed  three  times.  These  cells  were  then subsequently analyzed on  the 
Cytofluorograf and the intensity of fluorescence per cell recorded on a pulse height analyzer. 
Background staining was obtained by substituting a 0.15-ml aliquot of 1:1,000 ascites  from a 
BALB/c mouse injected intraperitoneally  with a nonproducing clone. 
In experiments designed to separate OKT3  +, OKT4  +, and OKT4- cells,  100  ×  106 cells 
were labeled with 4 ml of a  1  : 1,000 dilution of monoclonal antibody and developed with G/M 
FITC.  Utilizing the  fluorescence-activated cell  sorter  (FACS), T  cells  were  separated  into 
hybridoma reactive and nonreactive populations as previously described (17), Post sort viability 
was >95% by trypan blue exclusion in all instances. 
Analysis of FACS-separated T-Cell  Subsets with  OKII.  Unfractionated T  cells  obtained by 
affinity chromatography  and  E  rosetting,  nylon  passage  and  E  rosetting,  and/or  FA(]S 
separation with  OKT3 monoelonal antibody and  indirect  immunofluorescence, as  well  as 
FACS-fractionated OKT4  ÷ and OKT4- T-cell subsets were placed in culture at 2 ×  106 cells/ 
ml  in  RPMI-1640  (Grand  Island  Biological Co.)  containing 20%  human  AB  serum,  1% 
penicillin-streptomycin,  200 mM L-glutamine, 25 mM Hepes buffer (Microbiological Associ- 
ates),  and 0.05% sodium bicarbonate. After variable time intervals (1-9 d)  in 5% (]02 humid 
atmosphere at 37°C with or without mitogen, antigen, or alloantigen as activation stimuli, 1-2 
×  106  cells  of  each  population  were  reacted  with  OKI1  and  stained  with  G/M  FITC. 
Background staining was determined as described above. 
T-Cell Stimulation by Alloantigens, Soluble Antigens, and Mitogens.  T cells were stimulated with a 
B-lymphoblastoid line Laz  156 in MLC  and with doses of phytohemagglutinin (PHA)  and 
concanavalin  A (Con A) ranging from 0.1 to 0.01 #g and 50 to 250 #g, respectively, as previously 
described (12). Stimulation with tetanus toxoid was performed by utilizing 10 #g/ml tetanus E.  L.  REINHERZ ET AL.  1475 
toxoid (Massachusetts  Department of Public Health Biological Laboratories, Boston, Mass.). 
5% macrophages were added to all mitogen and soluble antigen stimulated populations at the 
initiation of cell cultures. 
Complement-Mediated Lysis of T  Cells.  Complement-mediated  lysis  of MLC-activated  or 
unactivated T cells with OKT3 and OKI1 were performed in microplate assay. 2 ×  106 T cells 
were treated  with 0.2 ml  [SaCr]sodium  chromate  (292 #Ci/ml)  (New England  Nuclear)  and 
incubated in a 37°C shaking water bath for 90 min. Cells were spun down, washed twice, and 
diluted to 2 ×  105/ml.  20 #1 of labeled target cells (4,000 cells) were added to microplate wells 
with 20 #1 of hybridoma antibody for 1 h at 20°C at dilutions between  10  -2 and  10  -7 done in 
triplicate.  Subsequently, 20 #1 of fresh rabbit complement (hl0 dilution)  was added to each 
well  and  incubated  at  37°C  for an additional  hour.  After incubation,  140/.tl  of media was 
added  to each  well  and  plates  were spun  for 5  min  at  300 g  and  100 #1 of supernate  was 
aspirated  and counted on a  gamma scintillation counter (Packard Instrument Co., Downers 
Grove, Ill.).  Freeze-thaw and spontaneous release samples included complement and  media. 
Specific complement mediated lysis was calculated using the following formula: 
Exp. -  SR 
Percent specific  lysis =  FT -  SR  ×  100; 
where Exp.  =  mean of the observed triplicate,  SR -- spontaneous release,  and  FT "  freeze 
thaw. 
For lysis of larger number of cells with antibody and complement, 20 ×  l0  s T  cells were 
spun down in 15-ml tubes (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.), 
1 ml  of OKI1  at  a  1:1,000  dilution  added,  resuspended,  and  incubated  for  1 h  at  20°C. 
Subsequently, 0. I ml fresh rabbit complement was added, resuspended and incubated for an 
additional hour in a shaking water bath at 37°C. Cells were spun down, washed twice, brought 
up in RPMI-1640 supplemented  with  20% human AB serum and placed  in culture with or 
without the alloantigen Laz 156. At the end of 6 d, these cells were harvested and analyzed for 
expression of OKI 1 antigen by indirect immunofluorescence. 
Results 
Characterization of OKI1 Antibody Reactivity on Normal Human Lymphoid Cells.  Highly 
purified  T,  B,  Null,  and  macrophage  populations  were  prepared  from  a  given 
individual's peripheral mononuclear population. Fig.  1 shows the fluorescence pattern 
of 10,000 cells obtained on the Cytofluorograf after reacting these populations with 
OKI 1 at a  1:1,000 dilution and G/M  FITC. As shown, the entire T-cell population 
obtained  by affinity chromatography and E  rosetting is unreactive.  In contrast,  the 
vast majority of B  cells and macrophages in excess of 90% were specifically reactive 
with OKI 1. In addition,  ~20% of Null cells are also reactive. An identical pattern of 
reactivity was seen with lymphocyte subpopulations from 20 other normal individuals 
(data not shown). 
Molecular Identification of the Antigen Defined by OKI1.  The cellular expression of the 
antigen  defined  by  OKI1  was  virtually  identical  to  that  defined  with  previously 
reported  alloantisera  and  heteroantisera  defining Ia antigens  (4).  To determine  the 
antigen identified by OKI 1, an immunoprecipitation  technique was employed utiliz- 
ing  a  B  lymphoblastoid  line,  Laz  388.  As  shown  in  Fig.  2,  OKI1  specifically 
precipitates two major bands from this Ia antigen-bearing cell line. These included a 
broad band centered at 34,000 dahons and a  sharper band at 29,000 dahons, which 
together  define  the  components  of the  Ia  antigen.  A  less  intense  band  at  30,000 
dahons is also seen. This has been previously observed utilizing heteroantisera specific 
for Ia and  may represent  a  breakdown  product  or biological  variant  of the  34,000 
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Fic.  1.  The reactivity of OKII with human lymphocyte subpopulations by indirect immunoflu- 
orescence (solid line). As shown, the human T-cell population  is unreaetive with OKI1  (1:1,000 
dilution). In contrast, the antigen defined by OKII is present on the vast majority of B cells and 
macrophages (>9,100 of 10,000 cells tested). In addition, OKI 1 reacts with 20% of human Null cells 
(2,207 of 10,000 cells tested). Background fluorescence staining  (dotted  line) was obtained  by 
incubating each population  with a  1:1,000 dilution  ascitic fluid from a mouse injected with a 
nonproducing clone. 
Expression of Ia-like Antigens on Activated and Unactivated T-Cell Subsets.  To explore in 
detail  the  possibility  that  human  peripheral  blood T  cells  bear  Ia-like  antigens,  T 
cells  were  initially  separated  by  several  isolation  techniques  and  the  entire  T-cell 
population or T-cell subset  further purified by using monoclonal antibodies  specific 
for  the  entire  T-cell  population  or  inducer  T-cell  subset.  These  T  cells  were  then 
examined for expression of Ia-like antigens before or after activation using the above 
monoclonal anti-Ia antibody. As shown in Fig. 3, T  cells selected by E  rosetting and 
reactivity with OKT3 were entirely unreactive with OKI1 after in vitro culture for 6 
d.  Similarly,  T  cells  selected  by  nylon  adherence  and  E  rosetting  were  likewise 
unreactive. Moreover, when these T  cells were fractionated on the FACS into OKT4 + 
and  OKT4-  T  cell  subsets,  there  was still  no evidence of reactivity.  Similar  results 
were obtained when T  cells were examined on days 1, 3, 4, and 9 in tissue culture. In 
contrast,  as shown in  Fig.  4, when T  cells were stimulated  by alloantigen  in MLC, 
~65-70% expressed OKI1 antigen on day 6. Greater than 98% of these MLC-activated 
lymphocytes were T  cells as assessed by E rosette capacity and reactivity with OKT3 
and indirect immunofluoreseence  (data not shown). 
In addition to the absence of detectable surface Ia-like molecules on resting T  cells 
by indirect  immunofluorescence,  the appearance  of Ia-like molecules on MLC  acti- 
vated T  cells was confirmed by complement lysis studies.  OKT3 + and complement 
were lytic for all T  cells to a  dilution of 10 -6. When this same T-cell population was 
treated  with  OKI1  and complement,  there  was no evidence of lysis at  any dilution 
(Fig. 5 A). After alloactivation, however, it could be seen that OKI 1 and OKT3 were 
now lytic for 75 and  100% of T  cells, respectively (Fig. 5 B). 
To determine whether Ia antigens appeared on all subsets of alloactivated T  cells, 
T  cells  were fractionated  into OKT4 + and  OKT4-  populations  and  stimulated  by 
alloantigen in MLC. As shown in Fig. 4, both OKT4 + and OKT4-  T  cells expressed 
Ia antigen after activation. In addition, Table I shows that PHA or Con A  activation 
of both OKT4 + and OKT4- T-cell subsets also induced the appearance of Ia antigens 
on a  fraction of T  cells.  However, it  should be noted that  these mitogens induced a E.  L.  REINHERZ  ET  AL.  1477 
FIo.  2.  Autoradiograph of OKI 1 immune complex with ~S-labeled B-cell line. Denatured chem- 
ically reduced  samples were  run on  a  large  7-20%  gradient acrylamide slab  gel.  Channels are 
labeled as follows:  A =  14C molecular weight standards; B =  nonspe¢ific clonal antibody; and C 
=  OKII ascites.  MW =  molecular weight. 
OKT3  +  OKT4  +  0KT4- 
Fluorescence  Intensity 
F=o.  3.  Absence of Ia-like molecules on resting human T cells. A highly purified T-cell population 
was obtained by  fluorescence-activated cell  sorting utilizing a  monoclonal hybridoma antibody 
reactive with the entire human T-cell population (OKT3) or a monoclonal antibody reactive with 
the human helper cell subset (OKT4+). As shown, neither the OKT3  + T  cells, nor the OKT4  + and 
OKT4- T  cell subsets contained lymphocytes which were reactive by indirect immunofluorescence 
with OKI1  (solid line). Background fluorescence staining (dotted line) was obtained as in Fig.  1. 
significantly smaller percentage  of T  cells to express Ia than  alloantigen.  In contrast, 
tetanus  toxoid induced  only the OKT4  + T  cell subset to express the Ia-like molecule. 
These  results  are  consistent  with  the  previous  observation  demonstrating  that  only 
the OKT4  +  population  proliferated  to soluble antigen  whereas all subpopulations  of 
T  cells proliferated  to mitogens  and  alloantigens  (12). 1478  Ia  DETERMINANTS ON  HUMAN  T  CELLS 
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FxG. 4.  Expression of Ia-like molecules on allogeneically activated T  cells. By indirect immunoflu- 
orescence ~_65% of the OKT3  + T  cells and OKT4  ÷ or OKT4- T-cell subsets expressed Ia antigen. 
The appearance of Ia-like molecules on T  cells may represent either an expansion 
of a small subset of Ia  + T  cells or, in contrast, a de novo biosynthesis of Ia molecules 
by a  significant  fraction of the  T-cell population.  The  following experiments  were 
performed in an effort to resolve these possibilities. T  cells were obtained and reacted 
with OKI1 and complement before initiation of MLC with Laz 156. At the end of 5 
d, these pretreated, allogeneically stimulated T  cells were again analyzed for expres- 
sion of Ia antigen.  As shown in Table II, pretreatment with OKI1 and complement 
did not  effect expression of Ia antigen,  and the results were not  dissimilar to those 
obtained  from pretreatment  with  OKI1  alone or control  ascites  and  complement. 
These  results  support  the  view  that  Ia  antigens  are  not  normally  expressed  on  a 
subpopulation of resting T  cells which is then expanded, or that resting T  cells have 
too few Ia determinants to be lysed by OKI 1 and complement. 
Discussion 
This study describes the production and characterization ofa monoclonal antibody, 
termed OKI 1, directed at a cell surface molecule found on the vast majority of human 
B  cells  and  macrophages  of  all  individuals  tested.  Immunoprecipitation  studies 
revealed that OKI 1 reacted with a  bimolecular glycoprotein membrane complex of 
29,000 and 34,000 dalton subunits. Antigens of a similar biochemical nature and cell 
surface distribution have been defined by heteroantisera, alloantisera, and monoclonal 
antibodies  to  Ia-like  molecules  in  man,  guinea  pigs,  and  mice  (1-4,  19-27).  The 
reactivity of OKI 1 with B lymphocytes from multiple individuals demonstrates a lack 
of polymorphism in the Ia-like antigen  being defined  by this monoclonal antibody 
and suggests that  it recognizes a  common framework determinant  similar to heter- 
oantisera described above (4).  In addition to B cells and macrophages, OKI 1 reacted 
with 20-30% of null cells by indirect immunofluorescence. On the other hand, no Ia 
antigen  was  detected  on  resting  human  T  cells  isolated  by  specific  monoclonal 
antibodies  defining  the  entire  T-cell  population  (OKT3 +)  or  the  human  inducer 
(helper) subset (OKT4+). However, after mitogen activation with PHA or Con A and 
alloactivation  in  MLC,  20  and  70%  of T  cells,  respectively, expressed  Ia  antigen. 
Moreover, with these activation stimuli, both the OKT4  + and OKT4- T-cell subsets 
expressed Ia antigen  to an equivalent  degree.  In contrast,  soluble antigens  induced 
the formation of Ia antigen on 20% of T  cells and these T  cells were all of the OKT4  ÷ 
subpopulation. 
In prior studies,  it was shown  that  both the OKT4  + and  OKT4-  T  cell  subsets 100 
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FIe.  5.  Lytic capacity of OKI 1 and complement on unactivated and activated T  cells. As shown, 
OKT3 and complement are lytic for both unactivated (A) and activated  (B) T  cells to a dilution of 
10  -~. In contrast, unactivated T  cells are not lysed by OKI ! and complement, whereas activated T 
cells are lysed to a dilution of 10 -n with a maximal lysis of 75% at a dilution of 10  -a. 
proliferated  to optimal mitogenic doses of PHA and  Con  A  and  in  MLC  (12).  In 
contrast,  it was shown that only the OKT4  + subset  proliferated to soluble antigen. 
The present finding suggests that only the OKT4  + subset can be induced by tetanus 
toxoid  to  express  Ia antigen.  Thus,  the  expression  of Ia antigen  on  an  individual 
subset of T  cells is clearly linked to the response of that subset to a  given activation 
stimulus.  Similarly, it has been shown that individuals with autoimmune or immu- 
nodeficiency states who have disorders of inducer or suppressor subsets possess T  cells 
which are Ia activated in vivo (28). Given the fact that the OKI 1 monoclonal antibody 
detected a common Ia antigen framework, it was not possible to determine whether 
specific  subset  restricted  Ia  antigens  exist  in  man.  Further  characterization  and 
resolution  of  unique  I-region  antigens  in  humans  will  come  from  studies  with 
antibodies reactive with restricted regions of the molecule and displayed on subsets of 
human lymphocytes. 
Immunofluorescence  studies  demonstrated  the  expression  of Ia  molecules  after 
activation in MLC and studies utilizing complement mediated lysis supported these 
findings. Unactivated T cells were not lysed by OKI 1 and complement at any dilution 
tested whereas after activation, T  cells were lysed by OKI 1 and complement even at 
an antibody dilution of 1:100,000. Furthermore, the percentage of cells lysed by OKI 1 
and  complement  was  consistent  with  that  defined  by  fluorescence.  To  determine 
whether the expression of Ia on a large percentage of T  cells after activation was the 
result of clonal expansion of a  small subset of T  cells expression Ia, T  cells were first 
pretreated  with  OKI1  and  complement.  This  pretreatment  did  not  eliminate  the 
appearance of Ia  + cells at the end of 6 d and the results were virtually indistinguishable 
from studies where the T  cells were not pretreated.  These findings support the view 
that elonal expansion is not the major mechanism of Ia expression following activation 1480  Ia  DETERMINANTS  ON  HUMAN  T  CELLS 
TABLE  I 
Expression of la-like Antigens  on T Cells after Activation 
Activation stimulus 
T  cells expressing Ia 
OKT3 +  OKT4 ÷  OKT4- 
%  %  % 
PHA  18  22  16 
Con A  20  16  15 
Laz  156m  70  65  70 
Tetanus toxoid  20  38  0 
TABLE  II 
Failure of OKI1 and Complement Pretreatment to Abrogate Expression of la- 
like Antigens on T  Cells after Allosensitization 
Pretreatment  T  cells expressing Ia-like 
molecules 
Control  MLC  Media 
OKI 1  Complement 
ascites  stimulated  control 
%  % 
+  -  +  66  0 
+  -  -  68  0 
-  +  +  70  0 
stimulus. Nevertheless, one could not exclude the possibility that resting T  cells have 
Ia antigens but too few to serve as targets for lysis by anti-Ia and complement. 
The present study re-affirms that the Ia molecule in man is not normally expressed 
on T  cells to any appreciable extent.  The utilization  of T-cell specific monoclonal 
antibodies  to  select  the  T-cell  population  for  analysis  provided  a  highly  selective 
purification  procedure.  There  is  the  possibility  that  prior  demonstration  of Ia on 
resting T  cells could have been due to contaminating macrophages, B cells, or Null 
cells. While the present study does not exclude the possibility that a small number of 
T  cells  bear  Ia-like  molecules,  the  percentage  of  Ia  +  T  cells  would  have  to  be 
considerably less than 5% of the peripheral T-cell population. Moreover, the synthesis 
of Ia-like molecules and the de novo expression at the level of the cell surface appears 
to represent unequivocal evidence of T-cell activation which is linked to the specific 
activation stimulus and the genetically defined program of the cell responding to that 
stimulus.  The use of a  monoclonal antibody directed  at  an  Ia-like framework may 
provide a  useful probe with which  to measure immunologic activation of human T 
lymphocytes. 
Summary 
The nature of Ia antigens which appear on human T  cells after activation and the 
stimuli required  for their expression was examined utilizing a  monoclonal antibody 
reactive  with  the  Ia  antigen  framework.  T  cells  were  purified  using  monoclonal 
antibodies directed either at the entire T-cell population (OKT3) or the T-cell inducer 
subset (OKT4). By indirect immunofluorescence, it was shown that the human T-cell E.  L.  REINHERZ ET AL.  1481 
population contains no detectable Ia  + cells in the resting state.  In contrast, in excess 
of 60% of the T-cell population expresses Ia antigen after alloactivation in the mixed 
lymphocyte culture. Moreover, these Ia antigens are expressed within both the OKT4 + 
and  OKT4-  subsets.  Similarly,  phytohemagglutinin  and  concanavalin  A  induced 
~20% of peripheral T  cells to express Ia antigen and the expression of these antigens 
is not restricted to either OKT4 subset. In contrast, only the inducer T-cell population 
which proliferates maximally to soluble antigen expresses Ia antigens after activation 
by tetanus toxoid. Thus, the expression of human Ia antigens on unique T-cell subsets 
depends  upon  the activation  stimuli  utilized  and  ability of the individual  subset  to 
respond to a  given stimulus.  Additional studies indicated  that Ia antigens appear on 
previously Ia- T  cells after activation  and  do not result  from clonal expansion  of a 
small subset of Ia  ÷ T  cells. 
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